Riskpilot← Back to searchSign inGet full accessLjungquist Medkonsult AB
ABActiveOrg 5591739973Skäretvägen 41Hospital activities · NACE 8610Est. 20181 employees
Revenue 2025
SEK 0
EBITDA margin
—
-128% vs 2024
Equity ratio
91.4%
Financial strength
Net profit 2025
SEK -13K
-135% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | -128% |
| Net profit | SEK -13K | -135% |
| Total assets | SEK 77K | -33% |
| Equity | SEK 70K | -15% |
| Employees | 1 | — |
Legal name
Ljungquist Medkonsult AB
Org number
5591739973
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
3 oktober 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Medicinsk konsultation, rådgivning och föreläsning inom human- och veterinärmedicin.
Address
Skäretvägen 41
Email
oskarljungquist@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 263 | 127 | 73 | 0 |
| Staff expenses | — | −12 | −6 | −3 | −0 |
| EBITDA | −15 | 232 | −207 | 45 | −13 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −15 | 232 | −207 | 45 | −13 |
| Net financials | — | −0 | 0 | 0 | 0 |
| Profit before tax | −15 | 232 | −207 | 45 | −13 |
| Tax | −0 | −45 | −19 | −9 | — |
| Net profit | −15 | 187 | −227 | 36 | −13 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 49 | 331 | 341 | 115 | 77 |
| Equity | 36 | 223 | 47 | 83 | 70 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 13 | 108 | 294 | 32 | 7 |
| Total debt | 13 | 108 | 294 | 32 | 7 |
EBITDA margin
-1284400.0%
This company
15.8%
Market median
-8129214% vs market
20212025
Equity ratio
91.4%
This company
38.2%
Market median
+139% vs market
20212025
Return on equity
-17.9%
This company
18.4%
Market median
-197% vs market
20212025
Net profit margin
-1252000.0%
This company
8.1%
Market median
-15456890% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DP Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ljungquist Medkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ditte Pia Ljungquist | Chief Executive Officer | 0 companies |
| Sven Oskar Anders Ljungquist | Chairman | 0 companies |
| Gunvor Christina Carlsson | Deputy Board Member | 0 companies |